GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 783 filers reported holding GLAXOSMITHKLINE PLC in Q2 2017. The put-call ratio across all filers is 0.75 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $350,000 | -23.6% | 8,031 | -22.7% | 0.03% | -19.5% |
Q4 2021 | $458,000 | -6.7% | 10,390 | -19.1% | 0.04% | -16.3% |
Q3 2021 | $491,000 | +25.3% | 12,840 | +30.5% | 0.05% | +22.5% |
Q2 2021 | $392,000 | +11.7% | 9,840 | 0.0% | 0.04% | +5.3% |
Q1 2021 | $351,000 | -3.0% | 9,840 | 0.0% | 0.04% | -9.5% |
Q4 2020 | $362,000 | -2.2% | 9,840 | +0.2% | 0.04% | -16.0% |
Q3 2020 | $370,000 | -7.7% | 9,823 | 0.0% | 0.05% | -13.8% |
Q2 2020 | $401,000 | +2.6% | 9,823 | -4.8% | 0.06% | -12.1% |
Q1 2020 | $391,000 | -21.3% | 10,323 | -2.5% | 0.07% | +8.2% |
Q4 2019 | $497,000 | +6.0% | 10,586 | -3.6% | 0.06% | -1.6% |
Q3 2019 | $469,000 | -0.6% | 10,986 | -6.9% | 0.06% | -1.6% |
Q2 2019 | $472,000 | -5.0% | 11,798 | -0.8% | 0.06% | -10.0% |
Q1 2019 | $497,000 | -9.3% | 11,898 | -17.0% | 0.07% | -19.5% |
Q4 2018 | $548,000 | -11.6% | 14,335 | -7.1% | 0.09% | +6.1% |
Q3 2018 | $620,000 | +0.3% | 15,427 | +0.7% | 0.08% | +74.5% |
Q2 2018 | $618,000 | +1.3% | 15,327 | -1.9% | 0.05% | -47.8% |
Q1 2018 | $610,000 | +22.7% | 15,627 | +11.4% | 0.09% | +26.8% |
Q4 2017 | $497,000 | -58.4% | 14,027 | -52.3% | 0.07% | -59.0% |
Q3 2017 | $1,194,000 | -7.4% | 29,425 | -1.7% | 0.17% | -11.7% |
Q2 2017 | $1,290,000 | +5.0% | 29,925 | +2.7% | 0.20% | -0.5% |
Q1 2017 | $1,229,000 | +6.2% | 29,138 | -3.0% | 0.20% | 0.0% |
Q4 2016 | $1,157,000 | -11.4% | 30,048 | -0.8% | 0.20% | -12.8% |
Q3 2016 | $1,306,000 | +5.1% | 30,288 | +5.7% | 0.23% | -1.3% |
Q2 2016 | $1,243,000 | +5.1% | 28,668 | -1.7% | 0.23% | -5.8% |
Q1 2016 | $1,183,000 | +17.4% | 29,178 | +16.8% | 0.24% | +14.6% |
Q4 2015 | $1,008,000 | -17.7% | 24,990 | -15.1% | 0.21% | -18.8% |
Q2 2015 | $1,225,000 | -15.2% | 29,421 | -6.0% | 0.26% | -14.7% |
Q1 2015 | $1,445,000 | -46.8% | 31,297 | -50.8% | 0.31% | +4.8% |
Q4 2014 | $2,718,000 | +24.8% | 63,624 | +34.3% | 0.29% | -38.3% |
Q3 2014 | $2,178,000 | -20.8% | 47,381 | -7.8% | 0.47% | -20.8% |
Q2 2014 | $2,749,000 | +0.3% | 51,406 | +0.3% | 0.60% | -10.1% |
Q1 2014 | $2,740,000 | +6.6% | 51,273 | +6.5% | 0.66% | +0.2% |
Q4 2013 | $2,570,000 | +1.1% | 48,149 | -5.0% | 0.66% | -7.9% |
Q3 2013 | $2,543,000 | +161.9% | 50,693 | +160.8% | 0.72% | +150.9% |
Q2 2013 | $971,000 | – | 19,434 | – | 0.29% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
OSTERWEIS CAPITAL MANAGEMENT INC | 1,948,915 | $79,029,000 | 4.59% |
Chubb Ltd | 400,000 | $16,220,000 | 4.42% |
Pegasus Partners Ltd. | 172,275 | $6,986,000 | 3.79% |
Keystone Financial Planning, Inc. | 117,762 | $4,775,000 | 3.42% |
P.R. Herzig & Co. Inc. | 36,950 | $1,498,000 | 3.28% |
Sterneck Capital Management, LLC | 112,535 | $4,563,000 | 3.21% |
Healthcare Value Capital, LLC | 50,000 | $2,028,000 | 2.98% |
Hamlin Capital Management, LLC | 1,454,031 | $58,961,000 | 2.98% |
Jolley Asset Management, LLC | 80,639 | $3,270,000 | 2.98% |
JFB Holdings Corp | 2,415,570 | $97,951,000 | 2.91% |